Advertisement

Topics

Latest "GL CHEMTEC INTERNATIONAL LIMITED" News Stories - Page: 2

11:47 EDT 24th March 2019 | BioPortfolio

Here are the most relevant search results for "GL CHEMTEC INTERNATIONAL LIMITED" found in our extensive news archives from over 250 global news sources.

More Information about GL CHEMTEC INTERNATIONAL LIMITED on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about GL CHEMTEC INTERNATIONAL LIMITED for you to read. Along with our medical data and news we also list GL CHEMTEC INTERNATIONAL LIMITED Clinical Trials, which are updated daily. BioPortfolio also has a large database of GL CHEMTEC INTERNATIONAL LIMITED Companies for you to search.

Showing "CHEMTEC INTERNATIONAL LIMITED" News Articles 26–50 of 5,300+

Thursday 21st March 2019

Robotic Surgery Market Expected to More than Double to $7 billion by 2025 – New Study by iData Research

Could your next surgery be done by a robot? With procedure volumes rising, there’s a good chance that this will be the case. Mirroring the quick-paced nature of new technological innovations, the surgical robotics market has experienced significant prosperity recently, which is expected to continue through 2025. Currently valued at over $3 billion, this ...


Imago BioSciences Announces $40 Million Series B Financing Led by Omega Funds

Imago BioSciences, Inc., a clinical-stage biotechnology company developing innovative treatments for myeloid diseases, today announced a $40 million Series B financing led by Omega Funds, a leading international investment firm that creates and invests in life sciences companies. Other investors participating in the round include existing investors Frazier...

Ligand to Receive Milestone and Royalties as Result of FDA Approval of Sage Therapeutics’ ZULRESSO™ (brexanolone) Injection

ZULRESSO is the first and only treatment specifically indicated for postpartum depression Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that it will receive a $3 million milestone payment as a result of the U.S. Food and Drug Administration’s (FDA) approval of Sage Therapeutics’ (NASDAQ: SAGE) ZULRESSOTM (brexanolone) injection for t...


How hawkish is the Chinese public? Quite.

International recruitment needed to fix NHS staff shortages says new report

The King’s Fund think-tank has claimed that in the next five years nurse shortages will double and GP gaps could potentially nearly triple to 7,000.

Giant X-ray ‘chimneys’ are exhaust vents for vast energies produced at Milky Way’s center

Baxter, bioMérieux partner to improve acute kidney injury treatment

Baxter and bioMérieux announced their collaboration at the International Symposium on Intensive Care and Emergency Medicine (ISICEM) this week. The companies did not disclose additional details about their The post Baxter, bioMérieux partner to improve acute kidney injury treatment appeared first on Compelo Medical Devices - Latest industry news and analysis.

ICH Consults On Guideline To Improve Bioanalytical Data Consistency

The finalization of a new international guideline that proposes a harmonized approach on bioanalytical method validation is e...

Aura Biosciences to Present Interim Phase 1b/2 Clinical Data for AU-011 at the International Society of Ocular Oncology 2019 Annual Meeting

Aura Biosciences, a leader in the development of novel targeted therapies in ocular oncology, today announced that interim clinical data from its Phase 1b/2 clinical trial evaluating the safety and efficacy of light-activated AU-011, the Company’s lead product candidate for the primary treatment of primary choroidal melanoma, will be highlighted in an or...

Novel plasmid could hold key to control of mosquito-borne illness

A team of international researchers may have identified a new way to control mosquito-borne illnesses, according to a new study published in the journal Nature Communications.

Advanz Ponders Photofrin Sale As It Weighs Deals in Europe

Advanz Pharma is considering slimming down its US operations as it searches for global product deals and company acquisitions in...   

PredictImmune Win Business Weekly Life Science Innovation (Product) Award

Developers of pioneering prognostic tools recognised for its innovative product development and contribution to life science discovery PredictImmune, developers of pioneering prognostic tools for guiding treatment options and improving patient outcomes in immune-mediated diseases, are delighted to have been awarded the Life Science Innovation award for...

Rare Diseases: PKU GOLIKE® Debuts in Germany

PKU GOLIKE®, the brand new generation of Phenylalanine (PHe)-free medical food for Phenylketonuria (PKU) dietary management, is now available in Germany and Austria, promoted and distributed directly by APR Applied Pharma Research s.a. (APR) through its local subsidiary, APR Deutschland. The company has taken advantage of the 33th Annual Meeting ...

This is the International Financial Centre (IFC) in Beijing. J.P. Morgan, Goldman, UBS, RBC, and other western firms are here.pic.twitter.com/MI2olmkB6M

This is the International Financial Centre (IFC) in Beijing. J.P. Morgan, Goldman, UBS, RBC, and other western firms are here. pic.twitter.com/MI2olmkB6M

RevMedx receives CE Mark for XGAUZE® self-expanding gauze

Manufacturer of the revolutionary XSTAT® technology will now have a second sterile wound dressing available in Europe and other International markets WILSONVILLE, Ore. (PRWEB) March 21, 2019 RevMedx, Inc., a global leader in innovative devices that control severe bleeding, today announced it has received CE (Conformité Européenne) Mark Certification for the XGAUZE wound dressing in...

Modra Pharmaceuticals Announces First Patients Treated in Phase IIa Metastatic Breast Cancer Trial

--Study will test efficacy and safety of novel docetaxel-based oral therapeutic-- Modra Pharmaceuticals B.V. (“Modra”) today announced that the first patients have been treated in its Phase IIa study in patients with recurrent or metastatic HER-2 negative breast cancer. The trial will evaluate the efficacy and safety of Modra’s lead product, Modr...

Drinking hot tea linked with elevated risk of oesophageal cancer

Previous studies have revealed a link between hot tea drinking and risk of oesophageal cancer, but until now, no study has examined this association using prospectively and objectively measured tea drinking temperature. A new International Journal of...

Adrenomed's Adrecizumab successfully passes interim analysis in early septic shock study AdrenOSS-II

DGAP-News: Adrenomed AG / Key word(s): Study/Statement 21.03.2019 / 09:15 The issuer is solely responsible for the content of this announcement. Adrenomed's Adrecizumab successfully passes interim analysis in early septic shock study AdrenOSS-II - AdrenOSS-II trial continues as planned after positive interim efficacy analysis triggered by the treatment of 50% of randomized patients -...

Why leaving the customs union might not be a good thing for pharma

Adam Johnson, director of logistics specialists Tudor International Freight discusses why pharma manufacturers might lose out if the UK leaves the customs union.

Samsung Bioepis Announces Three-year Follow-up Data for Biosimilar ONTRUZANT® (trastuzumab) in Early or Locally Advanced HER2-positive Breast Cancer

Three-year follow-up data show comparable overall survival between biosimilar ONTRUZANT® (trastuzumab) and reference medicine HERCEPTIN®i (trastuzumab)ii in early and locally advanced HER2-positive breast cancer Data presented today at the 16th St. Gallen International Breast Cancer Conference 2019 ...

Innovent Announces First Patient Dosed in a Phase IIa Clinical Study of IBI306, an Anti-PCSK9 Monoclonal Antibody

SUZHOU, China, March 21, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced that the first patient has been successfully dosed in a Phase IIa clinical study of IBI306, a recombinant fully human anti-proprotein convertase substilisin/kexin type 9 (anti-PCSK...

Japan expands international scientific links

Wednesday 20th March 2019

Global Variation of Nutritional Status in Children Undergoing Chronic Peritoneal Dialysis: A Longitudinal Study of the International Pediatric Peritoneal Dialysis Network

Researchers discover hidden differences between pathology of CTE and Alzheimer's disease

(Indiana University) An international team of scientists at Indiana University School of Medicine, University of Kansas and the U.K. Medical Research Council have dismantled the belief that Alzheimer's disease and Chronic Traumatic Encephalopathy have made a discovery that offers options for improved diagnosis and potential targeted treatments.

New brain research challenges our understanding of sleep

(Aarhus University) An international study headed by researchers from Aarhus University has for the first time uncovered the large-scale brain patterns and networks in the brain which control sleep, providing knowledge which in the future may can in the long term help the many Danes large proportion of people who experience problems sleeping.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks